CSIMarket
 


Concert Pharmaceuticals Inc   (CNCE)
Other Ticker:  
 

Concert Pharmaceuticals Inc 's Long Term Debt to Equity

CNCE's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




CNCE Long Term Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change 34.4 % 4.14 % -32.86 % -14.44 % -22.5 %
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ - - - - -
Overall Ranking Seq. Equity Change 4.29 % 66.9 % -31.77 % 13.17 % -19.19 %
Seq. Long Term Debt Change - - - - -



Long Term Debt to Equity third quarter 2022 Comment
In the third quarter 2022 Concert Pharmaceuticals Inc did not have Long Term Debt .

Within Major Pharmaceutical Preparations industry Concert Pharmaceuticals Inc achieved lowest Long Term Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
Learn more about CNCE
Long Term Debt to Equity Ratio CNCE on the trailing twelve month basis
Long Term Debt to Equity third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Concert Pharmaceuticals Inc 's Equity $ 133 Millions Visit CNCE's Balance sheet
Concert Pharmaceuticals Inc 's Long Term Debt $ 0 Millions Visit CNCE's Balance sheet
Source of CNCE's Sales Visit CNCE's Sales by Geography


Cumulative Concert Pharmaceuticals Inc 's Long Term Debt to Equity

CNCE's Long Term Debt to Equity for the trailling 12 Months

CNCE Long Term Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth 34.4 % 4.14 % -32.86 % -14.44 % -22.5 %
Y / Y Long Term Debt TTM Growth - - - - -
Long Term Debt to Equity TTM - - - - -
Total Ranking TTM Seq. Equity TTM Growth 4.29 % 66.9 % -31.77 % 13.17 % -19.19 %
Seq. Long Term Debt TTM Growth - - - - -


TTM Long Term Debt to Equity Comment
On the trailing twelve months basis In the III. Quarter Concert Pharmaceuticals Inc did not have Long Term Debt .
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry CNCE recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Long Term Debt to Equity Ratio?
Learn more about CNCE
Long Term Debt to Equity Ratio CNCE on the trailing twelve month basis

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


TTM Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Long Term Debt to EquitySep 30 2022 MRQ Long Term DebtSep 30 2022 MRQ Equity

Date modified: 2022-11-08T16:42:48+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LPI's Profile

Stock Price

LPI's Financials

Business Description

Fundamentals

Charts & Quotes

LPI's News

Suppliers

LPI's Competitors

Customers & Markets

Economic Indicators

LPI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071